manual on management of drugs

More documents

Recommendations

Info

(d) The Institutional Drug Therapeutic Committee (Drug Review Committee) An institutional Drug Therapeutic Committee should be established in all Teaching, Provincial, Specialized hospitals, District General, Base and Divisional Hospitals. The recommended membership of the committee is: Director/Medical Superintendent/Medical Officer in Charge - (Chairman) All Consultants – (if so staffed) Senior Medical Officer OPD Chief Pharmacist of the institution – (Secretary) Accountant - (if so staffed)) Special Grade Nursing Officer (Matron) or Senior Nursing Officer and in the case of small institutions, all prescribing officers. It is recommended that RDHS together with one or more of his staff namely Oic (R/MSD), Divisional Pharmacist, Divisional RMP should attend the meetings of the Drug Therapeutic Committee of the major institutions. At least one officer from amongst the above should attend all meetings. Officer in charge, R/MSD should compulsorily attend all Drug Review Committee meetings of Provincial and Base Hospitals. In the case of MOH division, the forum will be the monthly conference of the Medical Officer of Health with the field staff. The Committee should meet monthly. A copy of the minutes should be sent to the RDHS for necessary action. In the case of Provincial / District General and Base Hospitals, a copy of the minutes should in addition, be sent to the Director MSD. Its functions are: (i) Preparation of annual estimates of drugs (ii) Monitoring of supply and use of drugs in the institution. (iii)Monitoring of local purchases and use of special drugs in the institutions. (iv)Ensure economy in the use of drugs (v) Ensure adequate supply of critical/essential medicines in institutions 13
(vi) Ensure consumption of drugs within the financial allocation (vii)Any other functions assigned to it by the RDHS./Head of the Institution. 5. Specialized Institutions and campaigns Specialized campaigns[e.g.Anti Malaria, Anti Filariasis, Anti-Leprosy, Respiratory Diseases Control Programme and National Sexually transmitted Diseases & AIDS Control Programme (NSACP)] obtain their requirements of drugs from the Medical Supplies Division and distribute same to their respective regional or local level institutions. These specialized campaigns should also establish Drug Review Committee at the national level, Specialized Campaigns coming under Provinces should obtain their supplies through the R/MSD. 14
Page 2 and 3: MANUAL ON MANAGEMENT OF DRUGS SECON
Page 4 and 5: MESSAGE BY THE SECRETARY/ MINISTRY
Page 6 and 7: ACKNOWLEDGEMENT It is a great pleas
Page 8 and 9: Dr. J. M. J. Munasinghe Dr. K. C. L
Page 10 and 11: ABBREVIATIONS AD CP CDD CDDA D(F) D
Page 12 and 13: CONTENTS Message by the Hon. Minist
Page 14 and 15: X Form for Drug sample for quality
Page 16 and 17: CHAPTER 1 INTRODUCTION 1.Ensuring a
Page 18 and 19: 3.The expenditure on drugs has been
Page 20 and 21: of poisons, opium, and dangerous dr
Page 22 and 23: (Medical Technology & Supplies) No
Page 24 and 25: c) NDQAL for quality assurance of d
Page 26 and 27: Deputy Director General (Finance) D
Page 30 and 31: CHAPTER 4 ESTIMATION OF ANNUAL REQU
Page 32 and 33: Step 2 Identify the stock available
Page 34 and 35: In the case of institutions under t
Page 36 and 37: oard appointed by him and a report
Page 38 and 39: Head of the Institution may add any
Page 40 and 41: ii. Injections costing Rs. 25.00 or
Page 42 and 43: 42. Delivery schedules are planned
Page 44 and 45: CHAPTER 6 CARE IN PRESCRIBING DRUGS
Page 46 and 47: CHAPTER 7 DISTRIBUTION AND LOGISTIC
Page 48 and 49: the institution. Records of the inv
Page 50 and 51: RMSD or institutional stores, the o
Page 52 and 53: CHAPTER 8 QUALITY ASSURANCE OF DRUG
Page 54 and 55: ioavailability. Further, in apprais
Page 56 and 57: x. Details of any preservative adde
Page 58 and 59: To request institutions to inform t
Page 60 and 61: CHAPTER 9 STORAGE OF DRUGS. 1. Prop
Page 62 and 63: xi. Storage of vaccine in the refri
Page 64 and 65: CHAPTER 10 MONITORING OF CONSUMPTIO
Page 66 and 67: ii. VEN analysis ( See annexure XV
Page 68 and 69: 9. Monitoring of quality of drugs;
Page 70 and 71: alance as per ledger, actual balanc
Page 72 and 73: 1.3 In case of institutions coming
Page 74 and 75: Ampoules should be crushed and buri
Page 76 and 77: ANNEXURE I1: Main functions of Medi
Page 78 and 79:
I - Annual stock holding cost as a
Page 80 and 81:
Anti Rabies cell culture vaccine. (
Page 82 and 83:
unobservable (animal dead, killed,
Page 84 and 85:
on D0, D3, D7, D14 & D30. 6.1.2 For
Page 86 and 87:
All patients who receive rabies PET
Page 88 and 89:
Monthly return for vaccine consumpt
Page 90 and 91:
Death in the house / outside a Medi
Page 92 and 93:
2.2 In case of major exposures: 2.2
Page 94 and 95:
ANNEXURE - V MyNo……/…../….
Page 96 and 97:
Advertisement Screening Unit Unit o
Page 98 and 99:
ANNEXURE VIII (To be amended To: My
Page 100 and 101:
ANNEXURE X ……………………
Page 102 and 103:
6. Quality failure of registration
Page 105 and 106:
ANNEXURE XIII Lot Card SR No……
Page 107 and 108:
ANNEXURE XV VEN Analysis This analy
Page 109:
Sample Guidelines for VEN Category
Page 112 and 113:
Unsatisfactory clinical response, a
Page 114 and 115:
Local Agents of supplier (on reques
show all

manual on management of drugs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?